Covered recipient · General Payments record
CHANDA DANIELLE BABINEAUX
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$146.63
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $146.63 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ITI, Inc. | $73.21 | 4 |
| Neurocrine BioSciences, Inc. | $24.78 | 1 |
| Novo Nordisk AS | $18.62 | 1 |
| Acerta Pharma LLC | $16.80 | 1 |
| Lundbeck LLC | $13.22 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $146.63 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $16.80 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119660225 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.89 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143365107 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.05 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143365111 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.98 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143365114 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143365118 | CMS |
| Lundbeck LLC | $13.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145990281 | CMS |
| Neurocrine Biosciences, Inc. | $24.78 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150956139 | CMS |
| Novo Nordisk Inc | $18.62 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100306033 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.